Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer

Annette Wunderlich(Philipps University of Marburg), Sebastian Hoffmann(Witten/Herdecke University), Silvia Roth(Philipps University of Marburg), Detlef K. Bartsch(Philipps University of Marburg), Annette Ramaswamy(Philipps University of Marburg), Ulrike Hinterseher(Philipps University of Marburg), Brandon Greene(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg)
Endocrine
April 4, 2012
10.1007/s12020-012-9665-4
Cited by 18

Related Papers

Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
|Gut|2019|620
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
|Bone Marrow Transplantation|1999|259